Inhibition of DNA repair replication by DNA binding drugs which sensitize cells to alkylating agents and X-rays.
D000477:Alkylating Agents / Q000494:pharmacology*; D002110:Caffeine / Q000494:pharmacology; D002738:Chloroquine / Q000494:pharmacology*; D003486:Cyanides / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology*; D004260:DNA Repair / Q000187:drug effects; D004261:DNA Replication / Q000187:drug effects*; D004140:Dinitrophenols / Q000494:pharmacology; D004307:Dose-Response Relationship, Radiation; D004338:Drug Combinations; D006801:Humans; D006918:Hydroxyurea; D007274:Injections, Intraperitoneal; D007958:Leukocyte Count; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism; D011485:Protein Binding; D011796:Quinacrine / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D011830:Radiation Effects; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology*; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014466:Ultraviolet Rays
D000477:Alkylating Agents; D003486:Cyanides; D004140:Dinitrophenols; D004338:Drug Combinations; D011804:Quinolines; D011838:Radiation-Sensitizing Agents; D014316:Tritium; D002110:Caffeine; D002738:Chloroquine; D003520:Cyclophosphamide; D011796:Quinacrine; D013936:Thymidine; D006918:Hydroxyurea